ArticleMolecular therapy. Methods & clinical development2023

Novel engineered chimeric engulfment receptors trigger T cell effector functions against SIV-infected CD4+ T cells.

Daniel Corey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.